Emil R. Unanue

Emil Raphael Unanue (pronounced you-non-oo-ay)(born September 13, 1934) is an immunologist and the current Paul & Ellen Lacy Professor at Washington University School of Medicine. He is a member of the National Academy of Sciences, the American Academy of Arts and Sciences and the Institute of Medicine. He previously served as chair of the National Academy of Sciences Section of Microbiology and Immunology.

Emil Raphael Unanue
BornSeptember 13, 1934 (1934-09-13) (age 85)
Cuba
NationalityCuban
CitizenshipU.S.
Alma materUniversity of Havana
Known forResearch in immunology
Scientific career
FieldsScientist; Immunologist; Educator; [Autho]
InstitutionsHarvard University; Scripps Research Institute; Washington University in St. Louis
Doctoral studentsHerbert W. "Skip" Virgin

Area of expertise

Unanue is internationally recognized as an expert on immunological function, vis-a-vis the identification and T-cell response to foreign material, known to scientists as antigen. His work initiated a field of study known as antigen presentation; it is critical to the development of vaccines and underlies an understanding of microbial immunity and autoimmune diseases.

In the late 1970s, it was recognized that T lymphocytes could not recognize antigen directly and instead required an interaction with another specialized cell known as the Antigen-presenting cell. Nobel Prize winners, Rolf Zinkernagel and Peter C. Doherty showed that this recognition also required the antigen-presenting cell to be from the same genetic background as the T-cell. That observation, called MHC restriction, led to a conundrum; namely, that the ability of a T cell to recognize foreign antigen also required that it recognize "self." With Paul M. Allen, Ph.D., the Robert L. Kroc Professor at Washington University School of Medicine, Unanue discovered that peptides from foreign antigens were bound to a group of molecules known as the major histocompatibility complex (MHC). This peptide-MHC complex was shown to be recognized by T cells. Although the latter hypothesis was initially greeted with intense skepticism, a large body of work, generated over the last two decades, has confirmed its validity.

Education and early career

Emil Unanue received his doctorate from the University of Havana (Cuba) in 1960. He then immigrated to the United States and studied briefly at the University of Pittsburgh. Following that experience, Unanue was a postdoctoral research fellow at the Scripps Clinic and Research Foundation, now The Scripps Research Institute in La Jolla, California. With his mentor, Dr. Frank J. Dixon, he made a series of contributions to the field of renal pathophysiology by examining the immune basis of glomerulonephritis. Unanue then joined the group headed by Dr. Brigitte Askonas at the National Institute for Medical Research at Mill Hill in London. Together, Unanue & Askonas made the seminal observation that macrophages did not completely catabolize antigens, foreshadowing development of the field of antigen processing and presentation. In 1970, Unanue was given an appointment in the Department of Pathology at Harvard Medical School, where he quickly rose through the academic ranks to become the Mallinckrodt Professor of Immunopathology in 1974. While at Harvard University, he and his colleagues made observations in the areas of immunoglobulin capping on B cells and host defenses to bacteria such as Listeria monocytogenes. That work culminated in the conclusion that MHC molecules mediate the display of processed peptides to T cells.

Work at Washington University in St. Louis, Missouri

From 1985 to 2006, Unanue was the Chairman of Pathology and Immunology and Mallinckrodt Professor at Washington University School of Medicine. He was preceded in that position by Dr. Paul Eston Lacy, and succeeded by Dr. Herbert "Skip" Virgin. Unanue's current research focuses on the molecular mechanisms of antigen processing, the immunological basis of autoimmune diabetes, and immune responses to intracellular bacteria.

Awards
gollark: If it's possible to impose binding conditions on employees about non-competition even after they leave, I think the law is broken.
gollark: Facebook/employers have money, legislative bodies want money, legislative bodies make laws, legislative bodies make laws set by facebook/employers! Yay democracy!
gollark: I do find it *really* ridiculous that the law *allows* for such things, but whatever.
gollark: TJ09 works there.
gollark: Facebook or something.

References
  1. "Past Recipients". The American Association of Immunologists. Retrieved 19 September 2018.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.